| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 |
| filingDate |
1968-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1971-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46956000c092e2f0f0e77abde17aa427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a8658fae884d8ec26d79e2de534d034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ce384e25cf3d693d3afd4ad037cd8c2 |
| publicationDate |
1971-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-3558594-A |
| titleOfInvention |
Erythromycin aliphatic sulfate |
| abstract |
AMONG NEW ALIPHATIC SULFATE SALTS OF ERYTHROMYCIN, THE N-OCTADECYL SULFATE SALT ESPECIALLY EXHIBITS NOT ONLY SUSTAINED UNIFORM BLOOD SERUM LEVELS IN HUMANS THAT ARE SUPERIOR TO OTHER KNOWN SALT FORMS, BUT ALSO IS SO NEARLY TASTELESS THAT WHEN ADMINISTERED AS AN AQUEOUS SUSPENSION OR AS A CHEWABLE TABLET, IT A LACKS THE OBJECTIONABLE PRONOUNCED AND PROLONGED BITTER TASTE EXPERIENCED WITH ERYTHROMYCIN BASE AND OTHER ACID ADDITION SALTS, HENCE, CHEWABLE TABLETS, UNCOATED TABLETS AND AQUEOUS SUSPENSIONS ARE READILY ACCEPTABLE AS ORAL DOSAGE FORMS. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4264765-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4476120-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3922379-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4393053-A |
| priorityDate |
1968-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |